Vicore Pharma Holding AB (VCRE) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

Vicore Pharma Holding AB (VCRE) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $3.49B, listed on NASDAQ, employing roughly 40 people, carrying a beta of 0.15 to the broader market. Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Led by Ahmed Mousa, public since 2026-07-02.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for VCRE as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →